Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qlarion is a specialized data analytics and business intelligence firm that focuses on helping government agencies and healthcare organizations solve complex public health challenges through data-driven insights. The company is widely recognized for developing the Framework for Addiction Analysis and Community Transformation (FAACT), a cross-agency data-sharing platform designed to combat the opioid epidemic by providing real-time visibility into addiction trends and resource needs. Qlarion also played a critical role in the COVID-19 response by building analytical dashboards for state governments to monitor infection rates and hospital capacity. In 2021, the company was acquired by GCOM Software to expand its specialized analytics capabilities within the public sector and healthcare domains.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qlarion.